Robert N Taylor

No ORCID on file · 120 papers in corpus · active 1988-2024

Study types

  • article 86
  • review 20
  • book-chapter 7
  • other 5
  • book 1

Condition tags

  • endometriosis 100
  • mesh:D004715 66
  • infertility 18
  • mesh:D017699 5
  • dysmenorrhea 3
  • chronic_pelvic_pain 3
  • die_deep_infiltrating 2
  • dyspareunia 2
article 2024
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2024.02.004

This group was formed out of the conviction that endometriosis research has not progressed at a pace in proportion to disease severity and the negative impact on women's quality of life. Furthermore, advancement in our understanding of this…

article 2023
The American journal of pathology ·doi:10.1016/j.ajpath.2023.04.007
other 2023
Research square ·doi:10.21203/rs.3.rs-2870585/v1

Endometriosis is a common gynecological inflammatory disorder characterized by immune system dysregulation, which is involved in lesion initiation and progression. Studies have demonstrated that several cytokines are associated with the evo…

article 2023
Inflammation ·doi:10.1007/s10753-023-01862-x

Endometriosis is a common gynecological inflammatory disorder characterized by immune system dysregulation, which is involved in lesion initiation and progression. Studies have demonstrated that several cytokines are associated with the evo…

article 2022
·doi:10.1210/jendso/bvac150.1475

Abstract Endometriosis is a common gynecological inflammatory disorder, which is characterized by immune system dysregulation with initiation and progression. It affects 5% to 15% of reproductive-age women and is present in as many as 30% t…

article 2021
·doi:10.1210/clinem/dgab511

CONTEXT: Human embryonic implantation is regulated by neuroendocrine hormones, ovarian steroids, growth factors, and cytokines. Sympathetic innervation of the uterus also may play a role. OBJECTIVE: We tested the hypothesis that cabergoline…

article 2020
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2020.01.002
book-chapter 2020
·doi:10.1007/978-3-030-39903-0_14
book 2020
·doi:10.1007/978-3-030-57866-4
article 2020
·doi:10.1097/01.aog.0000663180.46470.c9

INTRODUCTION: Linzagolix is a new, investigational, non-peptide, GnRH receptor antagonist being developed to treat endometriosis-associated pain (EAP). The EDELWEISS trial was a Phase 2b, double-blind, randomized, placebo-controlled, multic…

book-chapter 2020
·doi:10.1007/978-3-030-57866-4_4
article 2020
·doi:10.1210/jendso/bvaa046.668

Abstract Endometriosis and uterine fibroids (leiomyomas) are benign gynecological disorders affecting 5-15% of women of reproductive age. They cause a wide range of symptoms including mild to severe pelvic pain and infertility. Due to a pau…

article 2020
·doi:10.1097/01.aog.0000663200.75027.38

INTRODUCTION: Linzagolix is a new investigational, non-peptide, oral GnRH receptor antagonist being developed to treat endometriosis-associated pain (EAP). The EDELWEISS trial was a Phase 2b, double-blind, randomized, placebo-controlled, mu…

article 2020
Fertility and sterility ·doi:10.1016/j.fertnstert.2020.02.114
review 2019
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2019.02.033
article 2019
Frontiers in pediatrics ·doi:10.3389/fped.2019.00195

Background. Endometriosis (EM) is a recognized co-morbid condition in women with chronic fatigue syndrome (CFS). This analysis evaluates the impact of EM on the health of women with CFS by comparing selected health characteristics and labor…

article 2019
Molecular human reproduction ·doi:10.1093/molehr/gaz045

Human blastocyst nidation in the uterus and successful pregnancy require coordinated endometrial expression of estrogen receptor (ER)-α, progesterone receptors (PR)-A and -B and the gap junction protein, connexin (Cx)43. Our prior work esta…

article 2019
·doi:10.1016/j.fertnstert.2019.07.935
article 2019
·doi:10.1210/js.2019-sat-200

Endometriosis is a chronic gynecological inflammatory disorder in which immune system dysregulation is thought to play a role in its initiation and progression. Current agency-approved hormonal therapies, including synthetic progestins, GnR…

review 2018
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.12521

Challenges intrinsic to the accurate diagnosis of endometriosis contribute to an extended delay between the onset of symptoms and clinical confirmation. Intraoperative visualization, preferably with histologic verification, is considered by…

article 2018
·doi:10.2174/1573404813666170614122110

Background: Endometriosis is characteristically defined as the presence of endometrial glands and stroma outside the uterine cavity. Despite an estimated prevalence of 10% in women, the specific etiology, molecular, and clinical aspects of …

article 2018
Journal of cellular physiology ·doi:10.1002/jcp.27360

Endometriosis is a chronic gynecological inflammatory disorder in which immune system dysregulation is thought to play a role in its initiation and progression. Due to altered sex steroid receptor concentrations and other signaling defects,…

review 2018
Nature reviews. Disease primers ·doi:10.1038/s41572-018-0008-5
article 2018
The American journal of pathology ·doi:10.1016/j.ajpath.2018.06.011
review 2018
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2018.01.006